NOVA WELLNESS GROUP BERHAD

KLSE (MYR): NOVA (0201)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

0.95

Today's Change

+0.015 (1.60%)

Day's Change

0.93 - 0.95

Trading Volume

101,800

Financial

Show?
Last 10 FY Result
AQR T4Q 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 51,402 49,777 40,482 34,266 29,695 25,300 24,541 13.31%
PBT 24,510 23,984 19,289 17,502 14,743 11,117 13,610 9.10%
Tax -5,193 -5,105 -4,732 -4,497 -3,801 -2,817 100 -
NP 19,317 18,879 14,557 13,005 10,942 8,300 13,710 1.50%
-
NP to SH 19,317 18,879 14,557 13,005 10,942 8,300 13,710 1.50%
-
Tax Rate 21.19% 21.29% 24.53% 25.69% 25.78% 25.34% -0.73% -
Total Cost 32,085 30,898 25,925 21,261 18,753 17,000 10,831 24.36%
-
Net Worth 98,500 98,500 95,323 85,790 76,258 27,580 205 363.87%
Dividend
AQR T4Q 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Div 8,473 6,354 5,719 1,747 1,588 - - -
Div Payout % 43.86% 33.66% 39.29% 13.44% 14.52% - - -
Equity
AQR T4Q 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Net Worth 98,500 98,500 95,323 85,790 76,258 27,580 205 363.87%
NOSH 317,743 317,743 317,743 317,743 317,743 317,743 935 328.92%
Ratio Analysis
AQR T4Q 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 37.58% 37.93% 35.96% 37.95% 36.85% 32.81% 55.87% -
ROE 19.61% 19.17% 15.27% 15.16% 14.35% 30.09% 6,664.69% -
Per Share
AQR T4Q 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 16.18 15.67 12.74 10.78 9.35 15.59 2,624.56 -73.58%
EPS 6.08 5.94 4.58 4.09 3.44 5.12 1,466.23 -76.33%
DPS 2.67 2.00 1.80 0.55 0.50 0.00 0.00 -
NAPS 0.31 0.31 0.30 0.27 0.24 0.17 0.22 8.05%
Adjusted Per Share Value based on latest NOSH - 317,743
AQR T4Q 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 16.17 15.66 12.73 10.78 9.34 7.96 7.72 13.30%
EPS 6.08 5.94 4.58 4.09 3.44 2.61 4.31 1.52%
DPS 2.67 2.00 1.80 0.55 0.50 0.00 0.00 -
NAPS 0.3099 0.3099 0.2999 0.2699 0.2399 0.0868 0.0006 372.32%
Price Multiplier on Financial Quarter End Date
AQR T4Q 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 31/03/22 31/03/22 30/06/21 30/06/20 28/06/19 - - -
Price 0.90 0.90 0.855 0.64 0.44 0.00 0.00 -
P/RPS 5.56 5.75 6.71 5.93 4.71 0.00 0.00 -
P/EPS 14.80 15.15 18.66 15.64 12.78 0.00 0.00 -
EY 6.76 6.60 5.36 6.40 7.83 0.00 0.00 -
DY 2.96 2.22 2.11 0.86 1.14 0.00 0.00 -
P/NAPS 2.90 2.90 2.85 2.37 1.83 0.00 0.00 -
Price Multiplier on Announcement Date
AQR T4Q 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 24/05/22 24/05/22 09/09/21 18/08/20 26/08/19 28/08/18 - -
Price 0.91 0.91 0.85 1.19 0.42 0.58 0.00 -
P/RPS 5.63 5.81 6.67 11.03 4.49 3.72 0.00 -
P/EPS 14.97 15.32 18.55 29.07 12.20 11.34 0.00 -
EY 6.68 6.53 5.39 3.44 8.20 8.82 0.00 -
DY 2.93 2.20 2.12 0.46 1.19 0.00 0.00 -
P/NAPS 2.94 2.94 2.83 4.41 1.75 3.41 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 50 of 827 comments

donkeycharles

easily RM2 stock, 2 more years maybe

2020-12-06 13:16

NPRA1985

UAE says Sinopharm vaccine has 86% efficacy against COVID-19

DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.

The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.

The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.

“The analysis shows no serious safety concerns,” it said.

It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.

https://www.reuters.com/article/health-coronavirus-emirates/update-1-u...

2020-12-09 15:26

NPRA1985

United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19

TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.

The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.

The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.

The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”

The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.

https://www.forbes.com/sites/roberthart/2020/12/09/united-arab-emirate...

2020-12-09 22:28

NPRA1985

Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.

“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.

“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.

SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.

https://asiatimes.com/2020/12/uae-gives-chinese-vaccines-a-shot-in-the...

2020-12-11 00:03

donkeycharles

dropping, shopping time

2020-12-14 20:25

The1994Investor

Post removed.Why?

2020-12-23 22:35

donkeycharles

when are they going to main board?

2020-12-29 17:16

HantuRaya2020

Baru je ade announcement

2021-01-07 18:25

Yiingb

Nova flying up soooooooon

2021-01-08 11:19

donkeycharles

how come?

2021-01-11 23:27

donkeycharles

still not transferred yet

2021-01-14 17:48

donkeycharles

wait until grow spider web

2021-01-18 18:36

shortinvestor77

On behalf of the Board, Kenanga IB wishes to inform that Bursa Securities had, vide its letter dated 19 January 2021, approved the Transfer under the “Health Care” sector.



The Transfer will take effect immediately two (2) market days upon the announcement to Bursa Securities on the transfer date via Bursa Link.



This announcement is dated 20 January 2021.
https://www.bursamalaysia.com/market_information/announcements/company...

2021-01-21 08:36

donkeycharles

still so flat, please rise

2021-01-21 10:09

donkeycharles

any news on hepar p clinical trials?

2021-01-29 13:56

NPRA1985

Post removed.Why?

2021-02-03 22:05

donkeycharles

so there's another announcement, and then have to wait for 2 days then only transfer to main board?

2021-02-07 15:28

MS1979

Date of transfer to main board will be on 11th February

2021-02-09 17:45

eMOU88

Good news

2021-02-09 22:47

MS1979

Interim Dividend and Special Dividend coming in March.

2021-02-10 09:36

Petronas

Post removed.Why?

2021-02-12 13:39

Foker

Shit stock

2021-02-16 13:39

Foker

Memang shit stock

2021-02-16 21:26

donkeycharles

if i sell my shares tmr on ex date, am i still entitled for the div?

2021-02-24 22:16

shortinvestor77

Yes, you are entitled.

2021-02-25 12:31

sell

Only Sinovac vaccine approved by NPRA and Pharmaniaga allowed to distribute not Nova Un Well.

Posted by donkeycharles > Jan 29, 2021 1:56 PM | Report Abuse
any news on hepar p clinical trials?

2021-03-02 23:15

sell

Bursa is not strict enough such that many conmen successful con many ikan bilis.

2021-03-02 23:31

sell

Shareholders just go to tiih for instance to view signed contracts and photos of signing also cannot meh?

2021-03-02 23:35

sell

Block all hanky panky things by conmen.

2021-03-02 23:38

donkeycharles

what do you mean? I'm asking about hepar

2021-03-09 09:14

Foker

Don't worry about hepar. Small Contributor

2021-03-09 15:28

shortinvestor77

Once third trial test on hepar passes after a few years, it will add much value to Nova.

2021-05-09 20:55

DobitaLim

Limit down soon

2021-05-13 16:05

mrmeow

NOVA will come, along with PHARMA & DPHARMA

2021-05-31 17:56

Moneycometome

Anyone knows Nova's new plant latest news? Is it already commissioning or still in construction?

2021-09-10 00:56

HantuRaya2020

Wa ingat sudah start sikit.
Steady je.. x exciting..

2021-10-20 09:37

projecti2016

Exit 0.90, good luck to rest of you

2021-11-02 18:41

HantuRaya2020

Mau jual ka simpan? Atau tunggu dividen?

2021-11-09 11:14

catalan

The Board of Directors of Nova Wellness Group Berhad wishes to announce the positive results from the recently completed Hepar-P clinical trial to assess its efficacy and safety in patients with Non-Alcoholic Fatty Liver Disease (NAFLD).

2021-11-09 21:11

HantuRaya2020

Boleh simpan?

2021-11-10 08:14

HantuRaya2020

AGM ada orang join? Wa lambat.. Ada apapapa info?

2021-11-16 15:21

catalan

Good quarter result..

2021-11-16 22:05

shortinvestor77

Wa lupa AGM walaupun registered earlier. Very good QR.

2021-11-18 10:40

Foker

Got free gift this agm

2021-11-18 18:44

Foker

Too bad for you

2021-11-18 18:44

Moneycometome

Yesterday 22/11 saw Nova's truck running on Kepong road. Haha good sign to continue hold it

2021-11-23 01:04

shortinvestor77

Not bad. Dividend in.

2021-12-08 16:23

SpicyMcDeluxe

kekw

2021-12-09 09:08

shortinvestor77

Good price at 0.93.

2021-12-15 12:11

Post a Comment